Literature DB >> 25061102

FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma.

Michele B Weiss1, Ethan V Abel2, Neda Dadpey1, Andrew E Aplin3.   

Abstract

UNLABELLED: The neural crest is a multipotent, highly migratory cell population that gives rise to diverse cell types, including melanocytes. Factors regulating the development of the neural crest and emigration of its cells are likely to influence melanoma metastasis. The transcription factor FOXD3 plays an essential role in premigratory neural crest development and has been implicated in melanoma cell dormancy and response to therapeutics. FOXD3 is downregulated during the migration of the melanocyte lineage from the neural crest, and our previous work supports a role for FOXD3 in suppressing melanoma cell migration and invasion. Alternatively, TWIST1 is known to have promigratory and proinvasive roles in a number of cancers, including melanoma. Using ChIP-seq analysis, TWIST1 was identified as a potential transcriptional target of FOXD3. Mechanistically, FOXD3 directly binds to regions of the TWIST1 gene locus, leading to transcriptional repression of TWIST1 in human mutant BRAF melanoma cells. In addition, depletion of endogenous FOXD3 promotes upregulation of TWIST1 transcripts and protein. Finally, FOXD3 expression leads to a significant decrease in cell migration that can be efficiently reversed by the overexpression of TWIST1. These findings uncover the novel interplay between FOXD3 and TWIST1, which is likely to be important in the melanoma metastatic cascade. IMPLICATIONS: FOXD3 and TWIST1 define distinct subgroups of cells within a heterogeneous tumor. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25061102      PMCID: PMC4163536          DOI: 10.1158/1541-7786.MCR-14-0170

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  48 in total

Review 1.  Melanoma.

Authors:  Arlo J Miller; Martin C Mihm
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

2.  A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal.

Authors:  Guangjin Pan; Jun Li; Yali Zhou; Hui Zheng; Duanqing Pei
Journal:  FASEB J       Date:  2006-06-21       Impact factor: 5.191

Review 3.  The emerging roles of forkhead box (Fox) proteins in cancer.

Authors:  Stephen S Myatt; Eric W-F Lam
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 4.  The making of a melanocyte: the specification of melanoblasts from the neural crest.

Authors:  Aaron J Thomas; Carol A Erickson
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

5.  Regulation of the actin cytoskeleton in cancer cell migration and invasion.

Authors:  Hideki Yamaguchi; John Condeelis
Journal:  Biochim Biophys Acta       Date:  2006-07-14

6.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

Review 7.  Melanoma: molecular pathogenesis and emerging target therapies (Review).

Authors:  Alessia E Russo; Elena Torrisi; Ylenia Bevelacqua; Rosario Perrotta; Massimo Libra; James A McCubrey; Demetrios A Spandidos; Franca Stivala; Grazia Malaponte
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

8.  Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.

Authors:  Stéphane Ansieau; Jeremy Bastid; Agnès Doreau; Anne-Pierre Morel; Benjamin P Bouchet; Clémence Thomas; Frédérique Fauvet; Isabelle Puisieux; Claudio Doglioni; Sara Piccinin; Roberta Maestro; Thibault Voeltzel; Abdelkader Selmi; Sandrine Valsesia-Wittmann; Claude Caron de Fromentel; Alain Puisieux
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

9.  In vivo switching of human melanoma cells between proliferative and invasive states.

Authors:  Keith S Hoek; Ossia M Eichhoff; Natalie C Schlegel; Udo Döbbeling; Nikita Kobert; Leo Schaerer; Silvio Hemmi; Reinhard Dummer
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

Review 10.  LIM kinases: function, regulation and association with human disease.

Authors:  Rebecca W Scott; Michael F Olson
Journal:  J Mol Med (Berl)       Date:  2007-02-10       Impact factor: 5.606

View more
  15 in total

1.  Screening of FOXD3 targets in lung cancer via bioinformatics analysis.

Authors:  Wenhua Jiang; Pengfei Liu; Xiaodong Li
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

2.  FOXD3 Regulates CSC Marker, DCLK1-S, and Invasive Potential: Prognostic Implications in Colon Cancer.

Authors:  Shubhashish Sarkar; Malaney R O'Connell; Yoshinaga Okugawa; Brian S Lee; Yuji Toiyama; Masato Kusunoki; Robert D Daboval; Ajay Goel; Pomila Singh
Journal:  Mol Cancer Res       Date:  2017-08-29       Impact factor: 5.852

3.  Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.

Authors:  Pooja G Talati; Lei Gu; Elyse M Ellsworth; Melanie A Girondo; Marco Trerotola; David T Hoang; Benjamin Leiby; Ayush Dagvadorj; Peter A McCue; Costas D Lallas; Edouard J Trabulsi; Leonard Gomella; Andrew E Aplin; Lucia Languino; Alessandro Fatatis; Hallgeir Rui; Marja T Nevalainen
Journal:  Am J Pathol       Date:  2015-09       Impact factor: 4.307

4.  Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors.

Authors:  Ehsan Bonyadi Rad; Heinz Hammerlindl; Christian Wels; Ulrich Popper; Dinoop Ravindran Menon; Heimo Breiteneder; Melitta Kitzwoegerer; Christine Hafner; Meenhard Herlyn; Helmut Bergler; Helmut Schaider
Journal:  Cancer Res       Date:  2016-01-22       Impact factor: 12.701

5.  FOXR2 contributes to cell proliferation and malignancy in human hepatocellular carcinoma.

Authors:  Xiao Wang; Bin He; Yong Gao; Yandong Li
Journal:  Tumour Biol       Date:  2016-02-05

Review 6.  Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.

Authors:  Stuart J Gallagher; Jessamy C Tiffen; Peter Hersey
Journal:  Cancers (Basel)       Date:  2015-09-25       Impact factor: 6.639

7.  Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.

Authors:  A Jain; R Tripathi; C P Turpin; C Wang; R Plattner
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

8.  FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway.

Authors:  Kun Li; Qunfeng Guo; Jun Yang; Hui Chen; Kewen Hu; Juan Zhao; Shunxin Zheng; Xiufeng Pang; Sufang Zhou; Yongyan Dang; Lei Li
Journal:  Oncotarget       Date:  2017-01-17

9.  Low‑intensity pulsed ultrasound promotes periodontal ligament stem cell migration through TWIST1‑mediated SDF‑1 expression.

Authors:  Yunji Wang; Jie Li; Ye Qiu; Bo Hu; Jin Chen; Tiwei Fu; Pengfei Zhou; Jinlin Song
Journal:  Int J Mol Med       Date:  2018-03-27       Impact factor: 4.101

10.  FOXD3 regulates anaplastic thyroid cancer progression.

Authors:  Huabin Yin; Tong Meng; Lei Zhou; Feixing Zhao; Xiufang Li; Yundong Li; Mengjun Hu; Haiyan Chen; Dianwen Song
Journal:  Oncotarget       Date:  2017-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.